Florida Man Arrested for Illegal Distribution of Information Relating to Explosives
JACKSONVILLE, FL - September 10, 2015 - United States Attorney A. Lee Bentley, III announces the arrest of Joshua Ryne Goldberg (20, Orange Park, Florida) for distributing information relating to explosives, destructive devices, and weapons of mass destruction. If convicted, he faces a maximum penalty of 20 years in federal prison.
According to the criminal complaint, Goldberg was in contact, through on-line communications, with an individual who law enforcement knew to be a Confidential Human Source (CHS). Between the months of July and September 2015, Goldberg distributed information to the CHS on how to manufacture a bomb. He instructed the CHS to make a pressure cooker bomb and fill it with nails, metal, and other items dipped in rat poison. Goldberg instructed the CHS to place the bomb at an upcoming memorial in Kansas City, Missouri that was commemorating the September 11, 2001 attacks. An complaint is merely a formal charge that a defendant has committed one or more violations of federal criminal law, and every defendant is presumed innocent unless, and until, proven guilty.
This case is being investigated by the FBI’s Joint Terrorism Task Force (JTTF) and the Clay County Sheriff’s Office. Members of the Jacksonville JTTF include the Federal Bureau of Investigation, the Naval Criminal Investigative Service, U.S. Immigration and Customs Enforcement’s Homeland Security Investigations, U.S. Customs and Border Protection, U.S. Border Patrol, the Florida Department of Law Enforcement, the Florida Highway Patrol, the St. Johns County Sheriff’s Office, and the Jacksonville Sheriff’s Office. It is being prosecuted by Assistant U.S. Attorney Kevin C. Frein of the Middle District of Florida, with assistance provided by Trial Attorney Mara Kohn of the National Security Division’s Counterterrorism Section.
U.S. Attorney’s Office
Middle District of Florida
This content has been reproduced from its original source.
Regeneron Pharmaceuticals' (Nasdaq: REGN) REGEN-COV2 is First Antibody Cocktail for COVID-19 to Receive FDA Emergency Use Authorization
